Edition:
India

Theratechnologies Inc (TH.TO)

TH.TO on Toronto Stock Exchange

6.93CAD
15 Dec 2017
Change (% chg)

$0.12 (+1.76%)
Prev Close
$6.81
Open
$6.80
Day's High
$6.97
Day's Low
$6.80
Volume
79,679
Avg. Vol
94,531
52-wk High
$8.72
52-wk Low
$2.61

Chart for

About

Theratechnologies Inc. is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess... (more)

Overall

Beta: 1.84
Market Cap(Mil.): $588.89
Shares Outstanding(Mil.): 74.92
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Theratechnologies Q3 loss per share c$0.04

* Theratechnologies announces financial results for third quarter of 2017

05 Oct 2017

BRIEF-Theratechnologies announces new findings with investigational Antiretroviral Ibalizumab, with EGRIFTA

* Theratechnologies Inc - announces new findings with investigational Antiretroviral Ibalizumab and with EGRIFTA

24 Jul 2017

BRIEF-Theratechnologies reports Q2 loss per share C$0.13

* Theratechnologies announces financial results for second quarter of 2017

12 Jul 2017

BRIEF-Theratechnologies says FDA sets PDUFA date of Jan 3 for ibalizumab application

* FDA grants priority review to HIV monoclonal antibody and long-acting investigational antiretroviral ibalizumab

30 Jun 2017

Earnings vs. Estimates